Compare Humira vs Hyrimoz head-to-head with other drugs for uses, ratings, cost, side effects and interactions.

HYRIMOZ is a biosimilar to Humira®. This means HYRIMOZ and Humira® are highly similar and have no clinically meaningful differences when it comes to safety, ...

28 авг. 2019 г. · Side effects of Hyrimoz that are different from Humira include infections (e.g. upper respiratory tract infection, sinusitis, urinary tract ...

In fact, with more than 119 million patient-days of experience in patients with inflammatory diseases, HYRIMOZ is a proven alternative to Humira® (adalimumab).

19 окт. 2023 г. · Humira indications include inflammatory bowel diseases (IBD: Crohn's disease and ulcerative colitis), chronic inflammatory rheumatism ...

11 окт. 2022 г. · Two adalimumab biosimilars, adalimumab-adaz and adalimumab-fkjp, demonstrated safety and effectiveness in patients with Crohn's disease and ulcerative colitis.

Laboratory studies comparing Hyrimoz with Humira have shown that the active substance in Hyrimoz is highly similar to that in Humira in terms of structure, ...

21 мар. 2023 г. · The study demonstrated comparable PK, as well as similar safety and immunogenicity between the 2 versions. ... ulcerative colitis and Crohn's ...

22 февр. 2023 г. · Choosing between available adalimumab products ... Humira 40mg with one exception: Hyrimoz is not licensed for paediatric ulcerative colitis.

Hyrimoz is considered to be biosimilar to Humira. In Canada, Humira is currently authorized for the treatment of rheumatoid arthritis, polyarticular juvenile ...